0001972362-23-000411.txt : 20230616 0001972362-23-000411.hdr.sgml : 20230616 20230616174119 ACCESSION NUMBER: 0001972362-23-000411 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 231022494 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Henderson Jane CENTRAL INDEX KEY: 0001422304 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC. STREET 2: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 144 1 primary_doc.xml 144 0001422304 XXXXXXXX LIVE 0001744659 Akero Therapeutics, Inc. 001-38944 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488 Henderson Jane Officer COMMON ETRADE FINANCIAL CORPORATION

3 EDISON DRIVE ALPHARETTA GA 30005

40000 2080000.00 50100000 06/16/2023 NASDAQ COMMON 06/16/2023 STOCK OPTION EXERCISE ISSUER N 40000 06/16/2023 COMPENSATION Y 06/16/2023 /s/ Jane V Henderson